LCE: an open web portal to explore gene expression and clinical associations in lung cancer.

Abstract:

:We constructed a lung cancer-specific database housing expression data and clinical data from over 6700 patients in 56 studies. Expression data from 23 genome-wide platforms were carefully processed and quality controlled, whereas clinical data were standardized and rigorously curated. Empowered by this lung cancer database, we created an open access web resource-the Lung Cancer Explorer (LCE), which enables researchers and clinicians to explore these data and perform analyses. Users can perform meta-analyses on LCE to gain a quick overview of the results on tumor vs non-malignant tissue (normal) differential gene expression and expression-survival association. Individual dataset-based survival analysis, comparative analysis, and correlation analysis are also provided with flexible options to allow for customized analyses from the user.

journal_name

Oncogene

journal_title

Oncogene

authors

Cai L,Lin S,Girard L,Zhou Y,Yang L,Ci B,Zhou Q,Luo D,Yao B,Tang H,Allen J,Huffman K,Gazdar A,Heymach J,Wistuba I,Xiao G,Minna J,Xie Y

doi

10.1038/s41388-018-0588-2

subject

Has Abstract

pub_date

2019-04-01 00:00:00

pages

2551-2564

issue

14

eissn

0950-9232

issn

1476-5594

pii

10.1038/s41388-018-0588-2

journal_volume

38

pub_type

杂志文章,meta分析

相关文献

ONCOGENE文献大全
  • Control of myeloid differentiation and survival by Stats.

    abstract::Hematopoiesis involves a complex array of growth factors that regulate the survival and proliferation of immature progenitors, influence differentiation commitment, and modulate end-stage cell functions. This mini-review is focused on the role of Stat activation in the development of myeloid cells in response to hemat...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1203477

    authors: Smithgall TE,Briggs SD,Schreiner S,Lerner EC,Cheng H,Wilson MB

    更新日期:2000-05-15 00:00:00

  • Significance of PELP1/HDAC2/miR-200 regulatory network in EMT and metastasis of breast cancer.

    abstract::Tumor metastasis is the leading cause of death among breast cancer patients. PELP1 (proline, glutamic acid and leucine rich protein 1) is a nuclear receptor coregulator that is upregulated during breast cancer progression to metastasis and is an independent prognostic predictor of shorter survival of breast cancer pat...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.332

    authors: Roy SS,Gonugunta VK,Bandyopadhyay A,Rao MK,Goodall GJ,Sun LZ,Tekmal RR,Vadlamudi RK

    更新日期:2014-07-10 00:00:00

  • Discovery of differentially expressed genes in human breast cancer using subtracted cDNA libraries and cDNA microarrays.

    abstract::Identifying novel and known genes that are differentially expressed in breast cancer has important implications in understanding the biology of breast tumorigenesis and developing new diagnostic and therapeutic agents. In this study we have combined two powerful technologies, PCR-based cDNA subtraction and cDNA microa...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205278

    authors: Jiang Y,Harlocker SL,Molesh DA,Dillon DC,Stolk JA,Houghton RL,Repasky EA,Badaro R,Reed SG,Xu J

    更新日期:2002-03-28 00:00:00

  • The transcription factor NRF2 enhances melanoma malignancy by blocking differentiation and inducing COX2 expression.

    abstract::The transcription factor NRF2 is the major mediator of oxidative stress responses and is closely connected to therapy resistance in tumors harboring activating mutations in the NRF2 pathway. In melanoma, such mutations are rare, and it is unclear to what extent melanomas rely on NRF2. Here we show that NRF2 suppresses...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-020-01477-8

    authors: Jessen C,Kreß JKC,Baluapuri A,Hufnagel A,Schmitz W,Kneitz S,Roth S,Marquardt A,Appenzeller S,Ade CP,Glutsch V,Wobser M,Friedmann-Angeli JP,Mosteo L,Goding CR,Schilling B,Geissinger E,Wolf E,Meierjohann S

    更新日期:2020-10-01 00:00:00

  • TPX2/Aurora kinase A signaling as a potential therapeutic target in genomically unstable cancer cells.

    abstract::Genomic instability is a hallmark feature of cancer cells, and can be caused by defective DNA repair, for instance due to inactivation of BRCA2. Paradoxically, loss of Brca2 in mice results in embryonic lethality, whereas cancer cells can tolerate BRCA2 loss. This holds true for multiple DNA repair genes, and suggests...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-018-0470-2

    authors: van Gijn SE,Wierenga E,van den Tempel N,Kok YP,Heijink AM,Spierings DCJ,Foijer F,van Vugt MATM,Fehrmann RSN

    更新日期:2019-02-01 00:00:00

  • MUC1-C activates BMI1 in human cancer cells.

    abstract::B-cell-specific Moloney murine leukemia virus integration site 1 (BMI1) is a component of the polycomb repressive complex 1 (PRC1) complex that is overexpressed in breast and other cancers, and promotes self-renewal of cancer stem-like cells. The oncogenic mucin 1 (MUC1) C-terminal (MUC1-C) subunit is similarly overex...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.439

    authors: Hiraki M,Maeda T,Bouillez A,Alam M,Tagde A,Hinohara K,Suzuki Y,Markert T,Miyo M,Komura K,Ahmad R,Rajabi H,Kufe D

    更新日期:2017-05-18 00:00:00

  • p53 inhibits mRNA 3' processing through its interaction with the CstF/BARD1 complex.

    abstract::The mechanisms involved in the p53-dependent control of gene expression following DNA damage have not been completely elucidated. Here, we show that the p53 C terminus associates with factors that are required for the ultraviolet (UV)-induced inhibition of the mRNA 3' cleavage step of the polyadenylation reaction, suc...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.29

    authors: Nazeer FI,Devany E,Mohammed S,Fonseca D,Akukwe B,Taveras C,Kleiman FE

    更新日期:2011-07-07 00:00:00

  • Downregulation of uPA inhibits migration and PI3k/Akt signaling in glioblastoma cells.

    abstract::The ability of glioma cells to migrate great distances from a primary tumor mass is the primary cause of tumor recurrence. The urokinase-type plasminogen activator (uPA) is a serine protease that can initiate proteolytic cascades, which result in remodeling of extracellular matrix and basement membrane, allowing cells...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206164

    authors: Chandrasekar N,Mohanam S,Gujrati M,Olivero WC,Dinh DH,Rao JS

    更新日期:2003-01-23 00:00:00

  • ZEB1-repressed microRNAs inhibit autocrine signaling that promotes vascular mimicry of breast cancer cells.

    abstract::During normal tumor growth and in response to some therapies, tumor cells experience acute or chronic deprivation of nutrients and oxygen and induce tumor vascularization. While this occurs predominately through sprouting angiogenesis, tumor cells have also been shown to directly contribute to vessel formation through...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2017.356

    authors: Langer EM,Kendsersky ND,Daniel CJ,Kuziel GM,Pelz C,Murphy KM,Capecchi MR,Sears RC

    更新日期:2018-02-22 00:00:00

  • Therapeutic efficacy of a DNA vaccine targeting the endothelial tip cell antigen delta-like ligand 4 in mammary carcinoma.

    abstract::The Notch ligand delta-like ligand 4 (DLL4) is an essential component expressed by endothelial tip cells during angiogenic sprouting. We have described a conceptually novel therapeutic strategy for targeting tumor angiogenesis and endothelial tip cells based on DNA vaccination against DLL4. Immunization with DLL4-enco...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2010.176

    authors: Haller BK,Bråve A,Wallgard E,Roswall P,Sunkari VG,Mattson U,Hallengärd D,Catrina SB,Hellström M,Pietras K

    更新日期:2010-07-29 00:00:00

  • EGF receptor binding and transformation by v-cbl is ablated by the introduction of a loss-of-function mutation from the Caenorhabditis elegans sli-1 gene.

    abstract::The 120 kD product of the c-cbl oncogene is rapidly tyrosine phosphorylated and recruited to the EGF receptor following ligand binding. Cbl's oncogenic potential is activated by a large carboxy-terminal truncation that generated v-cbl and removes the Ring finger and proline-rich SH3-binding domains. Here we show that ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201193

    authors: Thien CB,Langdon WY

    更新日期:1997-05-08 00:00:00

  • A role for Janus kinases in crosstalk between ErbB3 and the interferon-alpha signaling complex in myeloma cells.

    abstract::Receptor crosstalk is an emerging and recurrent theme in cytokine and growth factor signaling; however, insight into the mechanism(s) underlying these interactions remains limited. Recently, we reported that crosstalk occurs between ErbB3 and the interferon alpha (IFN-alpha) signaling complex in the myeloma cell line ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207203

    authors: Walters DK,Jelinek DF

    更新日期:2004-02-12 00:00:00

  • p53 induces the expression of its antagonist p73 Delta N, establishing an autoregulatory feedback loop.

    abstract::The p53 tumor suppressor protein activates transcription and induces cell death. A close homologue of p53, termed p73, is expressed in transactivating (TA) forms that induce growth arrest and apoptosis much like p53. However, the p73 gene contains a second promoter, giving rise to the expression of p73 Delta N, a spec...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205584

    authors: Kartasheva NN,Contente A,Lenz-Stöppler C,Roth J,Dobbelstein M

    更新日期:2002-07-18 00:00:00

  • Molecular cloning and characterization of the t(2;14) translocation associated with childhood chronic lymphocytic leukemia.

    abstract::Two rare cases of chronic lymphocytic leukemia (CLL) in children, patients AS and LH, have been found to be associated with a unique chromosomal translocation, t(2;14)(p13;q32). Previous studies have shown the breakpoints of this translocation to be in the gamma 2 switch region of the Ig heavy-chain locus on chromosom...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Richardson AL,Humphries CG,Tucker PW

    更新日期:1992-05-01 00:00:00

  • Distinct conformations of p53 are observed at different stages of keratinocyte differentiation.

    abstract::p53 is a multifunctional protein that has been shown to inhibit the growth of transformed cells, arrest the cell cycle of normal cells, regulate gene transcription and influence cellular differentiation, apoptosis and senescence. This study was undertaken to determine if the expression of p53 in keratinocytes varied d...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Spandau DF

    更新日期:1994-07-01 00:00:00

  • p120, a novel substrate of protein tyrosine kinase receptors and of p60v-src, is related to cadherin-binding factors beta-catenin, plakoglobin and armadillo.

    abstract::A novel protein tyrosine kinase (PTK) substrate, p120, has been previously implicated in ligand-induced signaling through the epidermal growth factor, platelet-derived growth factor and colony-stimulating factor 1 receptors, and in cell transformation by p60v-src. We have isolated a near full-length cDNA encoding muri...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Reynolds AB,Herbert L,Cleveland JL,Berg ST,Gaut JR

    更新日期:1992-12-01 00:00:00

  • The role of MAP4 expression in the sensitivity to paclitaxel and resistance to vinca alkaloids in p53 mutant cells.

    abstract::Mutations in p53 change the sensitivity to cancer chemotherapeutic drugs. Whereas many drugs, including the vinca alkaloids, often become less effective when p53 is transcriptionally inactivated, several, most notably paclitaxel, may become more effective. In studying the underlying mechanism(s), we found that increas...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201658

    authors: Zhang CC,Yang JM,White E,Murphy M,Levine A,Hait WN

    更新日期:1998-03-26 00:00:00

  • Cyclooxygenase inhibitors differentially modulate p73 isoforms in neuroblastoma.

    abstract::p73 encodes multiple functionally distinct isoforms. Proapoptotic TAp73 isoforms contain a transactivation (TA) domain, and like p53, have tumor suppressor properties and are activated by chemotherapies to induce cell death. In contrast, antiapoptotic DeltaNp73 isoforms lack the TA domain and are dominant-negative inh...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.59

    authors: Lau LM,Wolter JK,Lau JT,Cheng LS,Smith KM,Hansford LM,Zhang L,Baruchel S,Robinson F,Irwin MS

    更新日期:2009-05-14 00:00:00

  • Structural determinants of the BRCA1 : estrogen receptor interaction.

    abstract::Previously, we showed that the BRCA1 protein interacts directly and functionally with estrogen receptor-alpha (ER-alpha), resulting in the inhibition of estradiol (E2)-stimulated ER-alpha transcriptional activity. The interaction sites were mapped to the N-terminus of BRCA1 (within amino acids (aa) 1-302) and the liga...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208190

    authors: Ma YX,Tomita Y,Fan S,Wu K,Tong Y,Zhao Z,Song LN,Goldberg ID,Rosen EM

    更新日期:2005-03-10 00:00:00

  • Infrequent alteration of the c-myc gene in human glial tumours associated with increased numbers of c-myc positive cells.

    abstract::Twenty five human glial tumours of different grades of malignancy were examined by Southern blotting and polymerase chain reaction (PCR) for alterations (rearrangements, amplification and deletions) in the c-myc gene. Number of c-myc positive cells per thousand cells were also counted in all the tumours after immunohi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Chattopadhyay P,Banerjee M,Sarkar C,Mathur M,Mohapatra AK,Sinha S

    更新日期:1995-12-21 00:00:00

  • Cellular immune response to HTLV-1.

    abstract::There is strong evidence at the individual level and the population level that an efficient cytotoxic T lymphocyte (CTL) response to HTLV-1 limits the proviral load and the risk of associated inflammatory diseases such as HAM/TSP. This evidence comes from host population genetics, viral genetics, DNA expression microa...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1208970

    authors: Bangham CR,Osame M

    更新日期:2005-09-05 00:00:00

  • Requirement of the histone demethylase LSD1 in Snai1-mediated transcriptional repression during epithelial-mesenchymal transition.

    abstract::Epithelial-mesenchymal transition (EMT) has pivotal roles during embryonic development and carcinoma progression. Members of the Snai1 family of zinc finger transcription factors are central mediators of EMT and induce EMT in part by directly repressing epithelial markers such as E-cadherin, a gatekeeper of the epithe...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2010.234

    authors: Lin T,Ponn A,Hu X,Law BK,Lu J

    更新日期:2010-09-02 00:00:00

  • Methyltransferase inhibition induces p53-dependent apoptosis and a novel form of cell death.

    abstract::We have analysed the importance of proper substrate methylation by S-adenosylmethionine-dependent methyltransferases for cell survival and cell cycle progression. We show that treatment of cells with the methyltransferase inhibitor adenosine dialdehyde (AdOx) causes cell cycle arrest and death in different cell types....

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208855

    authors: Schwerk C,Schulze-Osthoff K

    更新日期:2005-10-27 00:00:00

  • The sirtuins promote Dishevelled-1 scaffolding of TIAM1, Rac activation and cell migration.

    abstract::Rac1-GTPases serve as intermediary cellular switches, which conduct transient and constitutive signals from upstream cues, including those from Ras oncoproteins. Although the sirtuin1 (SIRT1) deacetylase is overexpressed in several human cancers and has recently been linked to cancer cell motility as a context-depende...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.549

    authors: Saxena M,Dykes SS,Malyarchuk S,Wang AE,Cardelli JA,Pruitt K

    更新日期:2015-01-08 00:00:00

  • Alternative splicing of the ErbB-4 cytoplasmic domain and its regulation by hedgehog signaling identify distinct medulloblastoma subsets.

    abstract::Medulloblastoma (MB) results from aberrant development of cerebellar neurons in which altered hedgehog (Hh) signalling plays a major role. We investigated the possible influence of Hh signalling on ErbB-receptor expression in MB, in particular that of the ErbB-4 CYT-1 and CYT-2 isoforms generated by alternative splici...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209716

    authors: Ferretti E,Di Marcotullio L,Gessi M,Mattei T,Greco A,Po A,De Smaele E,Giangaspero F,Riccardi R,Di Rocco C,Pazzaglia S,Maroder M,Alimandi M,Screpanti I,Gulino A

    更新日期:2006-11-23 00:00:00

  • Functional analyses of the TEL-ARNT fusion protein underscores a role for oxygen tension in hematopoietic cellular differentiation.

    abstract::The transcription factor hypoxia inducible factor 1 (HIF1), an HIF1alpha-aryl hydrocarbon receptor nuclear translocator (ARNT) dimeric factor, is essential to the cellular response to hypoxia. We described a t(1;12)(q21;p13) chromosomal translocation in human acute myeloblastic leukemia that involves the translocated ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209503

    authors: Nguyen-Khac F,Della Valle V,Lopez RG,Ravet E,Mauchauffé M,Friedman AD,Huang LE,Fichelson S,Ghysdael J,Bernard OA

    更新日期:2006-08-10 00:00:00

  • Butyrolactone I, a selective inhibitor of cdk2 and cdc2 kinase.

    abstract::We screened cdc2 kinase inhibitors from cultured mediums of micro organisms using purified mouse cyclin B-cdc2 kinase and a specific substrate peptide for cdc2 kinase. A selective inhibitor of cdc2 kinase was isolated from the cultured medium of Aspergillus species F-25799, and identified as butyrolactone I. Butyrolac...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Kitagawa M,Okabe T,Ogino H,Matsumoto H,Suzuki-Takahashi I,Kokubo T,Higashi H,Saitoh S,Taya Y,Yasuda H

    更新日期:1993-09-01 00:00:00

  • Base changes in tumour DNA have the power to reveal the causes and evolution of cancer.

    abstract::Next-generation sequencing (NGS) technology has demonstrated that the cancer genomes are peppered with mutations. Although most somatic tumour mutations are unlikely to have any role in the cancer process per se, the spectra of DNA sequence changes in tumour mutation catalogues have the potential to identify the mutag...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2016.192

    authors: Hollstein M,Alexandrov LB,Wild CP,Ardin M,Zavadil J

    更新日期:2017-01-12 00:00:00

  • Prevalence and specificity of LKB1 genetic alterations in lung cancers.

    abstract::Germline LKB1 mutations cause Peutz-Jeghers syndrome, a hereditary disorder that predisposes to gastrointestinal hamartomatous polyposis and several types of malignant tumors. Somatic LKB1 alterations are rare in sporadic cancers, however, a few reports showed the presence of somatic alterations in a considerable frac...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210418

    authors: Matsumoto S,Iwakawa R,Takahashi K,Kohno T,Nakanishi Y,Matsuno Y,Suzuki K,Nakamoto M,Shimizu E,Minna JD,Yokota J

    更新日期:2007-08-30 00:00:00

  • Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels.

    abstract::Among surface molecules expressed on endothelial cells, endoglin (CD105) is emerging as a prime vascular target for antiangiogenetic cancer therapy. CD105 is a cell membrane glycoprotein mainly expressed on endothelial cells and overexpressed on tumor-associated vascular endothelium, which functions as an accessory co...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1206813

    authors: Fonsatti E,Altomonte M,Nicotra MR,Natali PG,Maio M

    更新日期:2003-09-29 00:00:00